These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

52 related items for PubMed ID: 1898532

  • 1. Influence of pravastatin on hepatic metabolism of cholesterol.
    Hellerstein M.
    N Engl J Med; 1991 Jan 10; 324(2):128. PubMed ID: 1898532
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of pravastatin on biliary lipid composition and bile acid synthesis in familial hypercholesterolaemia.
    Hoogerbrugge-vd Linden N, de Rooy FW, Jansen H, van Blankenstein M.
    Gut; 1990 Mar 10; 31(3):348-50. PubMed ID: 2108908
    [Abstract] [Full Text] [Related]

  • 4. Lovastatin, pravastatin, and serum lipoprotein(a).
    Jacob BG, Richter WO, Schwandt P.
    Ann Intern Med; 1990 May 01; 112(9):713-4. PubMed ID: 2139768
    [No Abstract] [Full Text] [Related]

  • 5. Apolipoprotein(a) and ischaemic heart disease.
    Jones AF, Lemon M, Bain SC, Walker MR.
    Lancet; 1990 Sep 29; 336(8718):813-4. PubMed ID: 1976174
    [No Abstract] [Full Text] [Related]

  • 6. Effects of pravastatin (CS-514) on biliary lipid metabolism in patients with hyperlipidemia.
    Horiuchi I, Ohya T, Tazuma S, Mizuno T, Takizawa I, Kajiyama G.
    Metabolism; 1991 Mar 29; 40(3):226-30. PubMed ID: 1900342
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of rat brain prostaglandin D synthase by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Islam F, Watanabe Y, Hayaishi O.
    Biochem Int; 1990 Nov 29; 22(4):601-5. PubMed ID: 2127671
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of pravastatin on hepatic cholesterol metabolism].
    Reihnér E, Rudling M, Ståhlberg D, Berglund L, Ewerth S, Björkhem I, Einarsson K, Angelin B.
    Fortschr Med; 1991 Mar 20; 109(8):189-94. PubMed ID: 1905265
    [Abstract] [Full Text] [Related]

  • 11. Effect of a new synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on cholesterol synthesis and low density lipoprotein uptake by primary cultures of rat hepatocytes.
    Saito Y, Shiki Y, Shirai K, Yoshida S.
    Arzneimittelforschung; 1988 Feb 20; 38(2):251-3. PubMed ID: 3130840
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effectiveness of pravastatin and bezafibrate in primary hypercholesterolemia].
    Arntz HR, Bönner G, Kikis D, Kirch W, Klör HU, Lederle RM, Overlack A, Steinmetz A, Stumpe KO.
    Dtsch Med Wochenschr; 1991 Jan 04; 116(1):7-12. PubMed ID: 1898717
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pravastatin--ocular side effects after a two year follow-up?
    Behrens-Baumann W, Thiery J, Fieseler HG, Seidel D.
    Lens Eye Toxic Res; 1990 Jan 04; 7(3-4):311-8. PubMed ID: 2129219
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of atorvastatin and pravastatin on serum C-reactive protein.
    Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Taylor AJ.
    Am Heart J; 2003 Feb 04; 145(2):e8. PubMed ID: 12595863
    [Abstract] [Full Text] [Related]

  • 18. CS-514 suppresses plasma triglyceride in hypertriglyceridemic subjects without modifying a lipoprotein structural model.
    Yoshino G, Kazumi T, Iwai M, Kasama T, Iwatani I, Matsuba K, Inui A, Uenoyama R, Yokono K, Otsuki M.
    Horm Metab Res; 1987 Oct 04; 19(10):513-4. PubMed ID: 3123351
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.